Cargando…
Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study
BACKGROUND: In a previous study, autologous bone marrow infusion (ABMI) was performed in patients with decompensated liver cirrhosis (DLC) and acquired immunodeficiency syndrome and achieved good results, but whether splenectomy affected outcome was unclear. AIM: To investigate the efficacy of ABMI...
Autores principales: | Liu, Bao-Chi, Cheng, Ming-Rong, Lang, Lin, Li, Lei, Si, Yan-Hui, Li, Ai-Jun, Xu, Qing, Zhang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600764/ https://www.ncbi.nlm.nih.gov/pubmed/37901728 http://dx.doi.org/10.4240/wjgs.v15.i9.1919 |
Ejemplares similares
-
Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy
por: Zhang, Weiwei, et al.
Publicado: (2018) -
Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus
por: Liu, Baochi, et al.
Publicado: (2021) -
Machine learning predicts portal vein thrombosis after splenectomy in patients with portal hypertension: Comparative analysis of three practical models
por: Li, Jian, et al.
Publicado: (2022) -
Elective Splenectomy Combined with Modified Hassab's or Sugiura Procedure for Portal Hypertension in Decompensated Cirrhosis
por: Zhang, Ya-wu, et al.
Publicado: (2019) -
Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)